CAPRICOR THERAPEUTICS, INC. — Revenue by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d8546612-4f2f-4a45-8aad-49cbdefe67f7/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-029580 |
| FY 2024 | $22.3M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-003707 |
| FY 2023 | $25.2M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002861 |
| FY 2022 | $2.6M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-004124 |
| FY 2021 | $244.9k | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-003341 |
| FY 2020 | $310.2k | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-036410 |
| FY 2019 | $1.0M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-039272 |
| FY 2018 | $1.7M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-016787 |
| FY 2017 | $2.7M | 2017-01-01 – 2017-12-31 | evidence 0001144204-19-016787 |
| FY 2016 | $4.0M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-014866 |
| FY 2015 | $5.5M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-091632 |
| FY 2014 | $4.8M | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-016469 |
| FY 2013 | $5.2M | 2005-07-05 – 2014-03-31 | evidence 0001144204-14-031429 |
| FY 2012 | $2.0M | 2005-08-01 – 2013-03-31 | evidence 0001144204-13-036078 |
| FY 2011 | $2.0M | 2005-08-01 – 2012-03-31 | evidence 0001144204-12-029535 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CAPRICOR THERAPEUTICS, INC. — all facts · Net Income · Operating Income